NO975286L - Promotere for genekspresjon - Google Patents

Promotere for genekspresjon

Info

Publication number
NO975286L
NO975286L NO975286A NO975286A NO975286L NO 975286 L NO975286 L NO 975286L NO 975286 A NO975286 A NO 975286A NO 975286 A NO975286 A NO 975286A NO 975286 L NO975286 L NO 975286L
Authority
NO
Norway
Prior art keywords
promoters
promote
gene expression
region
promoter
Prior art date
Application number
NO975286A
Other languages
English (en)
Other versions
NO975286D0 (no
NO325879B1 (no
Inventor
Peter A Lagosky
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO975286D0 publication Critical patent/NO975286D0/no
Publication of NO975286L publication Critical patent/NO975286L/no
Publication of NO325879B1 publication Critical patent/NO325879B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/72Expression systems using regulatory sequences derived from the lac-operon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975286A 1995-05-19 1997-11-18 Rekombinant DNA-konstruksjon nyttig for uttrykking av protein og en vektor. NO325879B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,133 US5629205A (en) 1995-05-19 1995-05-19 Promoters for gene expression
PCT/IB1996/000462 WO1996036721A1 (en) 1995-05-19 1996-05-16 Promoters for gene expression

Publications (3)

Publication Number Publication Date
NO975286D0 NO975286D0 (no) 1997-11-18
NO975286L true NO975286L (no) 1997-11-18
NO325879B1 NO325879B1 (no) 2008-08-11

Family

ID=23767732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975286A NO325879B1 (no) 1995-05-19 1997-11-18 Rekombinant DNA-konstruksjon nyttig for uttrykking av protein og en vektor.

Country Status (24)

Country Link
US (1) US5629205A (no)
EP (1) EP0828844B1 (no)
JP (2) JP3828576B2 (no)
KR (1) KR19990014906A (no)
CN (1) CN1131313C (no)
AT (1) ATE248923T1 (no)
AU (1) AU698656B2 (no)
BR (1) BR9609102A (no)
CA (1) CA2221587C (no)
CZ (1) CZ357997A3 (no)
DE (1) DE69629808T2 (no)
DK (1) DK0828844T3 (no)
EE (1) EE9700355A (no)
ES (1) ES2202436T3 (no)
HU (1) HUP9900750A3 (no)
IS (1) IS4609A (no)
MX (1) MX9708689A (no)
NO (1) NO325879B1 (no)
NZ (1) NZ306536A (no)
PL (1) PL324226A1 (no)
PT (1) PT828844E (no)
SK (1) SK154997A3 (no)
TR (1) TR199701394T1 (no)
WO (1) WO1996036721A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194168B1 (en) * 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
EP1572720A4 (en) * 2002-05-24 2008-12-24 Nps Allelix Corp PROCESS FOR THE ENZYMATIC PRODUCTION OF GLP-2 (1-34) AND GLP-2 (1-33) PEPTIDES
US20050119183A1 (en) * 2003-11-12 2005-06-02 Nps Allelix Corp. Method for treating bone loss using parathyroid hormone
WO2005067368A2 (en) * 2003-11-21 2005-07-28 Nps Allelix Corp. Production of glucagon like peptide 2 and analogs
US20060177895A1 (en) * 2003-12-12 2006-08-10 Chung Chan Methods for enhancing expression of recombinant proteins
RU2746407C1 (ru) 2012-02-23 2021-04-13 Стейдж Селл Терапеутикс Гмбх Хроматографическое выделение клеток и других сложных биологических материалов
US11248238B2 (en) 2015-10-22 2022-02-15 Juno Therapeutics Gmbh Methods, kits, agents and apparatuses for transduction
JP7194020B2 (ja) 2015-10-22 2022-12-21 ジュノ セラピューティクス ゲーエムベーハー 細胞の培養方法ならびにそのためのキットおよび装置
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
CN108060168B (zh) * 2017-12-29 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108118058B (zh) 2017-12-29 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其应用
CN108118059B (zh) 2017-12-30 2021-03-19 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的载体和应用
CN108165551B (zh) * 2017-12-30 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
AU2019337392B2 (en) * 2018-09-11 2025-03-27 Boehringer Ingelheim Rcv Gmbh & Co Kg Inducible expression system for plasmid-free production of a protein of interest
EP3874024A1 (en) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Methods for selection and stimulation of cells and apparatus for same
CN118995554B (zh) * 2024-09-09 2025-07-04 江南大学 一种大肠杆菌整合表达体系及其在酶高效表达中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517071D0 (en) * 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
DK443288A (da) * 1987-08-17 1989-02-18 Hoffmann La Roche Ekspressionskontrolsekvenser
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
DE69111456T2 (de) * 1990-08-28 1996-02-22 Du Pont Eine methode für die schnelle selektion von effizienten sekretionsvektoren.

Also Published As

Publication number Publication date
DK0828844T3 (da) 2004-01-05
US5629205A (en) 1997-05-13
EP0828844B1 (en) 2003-09-03
JP2006187295A (ja) 2006-07-20
CZ357997A3 (cs) 1998-04-15
DE69629808D1 (de) 2003-10-09
AU698656B2 (en) 1998-11-05
AU5511696A (en) 1996-11-29
EE9700355A (et) 1998-06-15
ATE248923T1 (de) 2003-09-15
JP3837154B2 (ja) 2006-10-25
SK154997A3 (en) 1998-05-06
KR19990014906A (ko) 1999-02-25
JP3828576B2 (ja) 2006-10-04
DE69629808T2 (de) 2004-07-15
MX9708689A (es) 1998-02-28
ES2202436T3 (es) 2004-04-01
HUP9900750A3 (en) 1999-11-29
WO1996036721A1 (en) 1996-11-21
CN1131313C (zh) 2003-12-17
TR199701394T1 (xx) 1998-02-21
CA2221587C (en) 2008-07-08
PT828844E (pt) 2004-01-30
NO975286D0 (no) 1997-11-18
BR9609102A (pt) 1999-05-11
CN1190993A (zh) 1998-08-19
PL324226A1 (en) 1998-05-11
NZ306536A (en) 1999-10-28
HK1004148A1 (en) 1998-11-20
JPH11509083A (ja) 1999-08-17
HUP9900750A2 (hu) 1999-06-28
EP0828844A1 (en) 1998-03-18
NO325879B1 (no) 2008-08-11
IS4609A (is) 1997-11-07
CA2221587A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
NO975286D0 (no) Promotere for genekspresjon
AU8131294A (en) Human kunitz-type protease inhibitors
BR9608149A (pt) Variante de subtilase processos para efetuar a mutação no dna que codifica uma enzima de subtilase para a manufatura de uma enzima de subtilase mutante e para produzir a variante sequência de dna vetor e hospedeiro microbiano
BG102612A (en) Complementary adenoviral vector systems and cellular lines
DE69634412D1 (de) Regulierte gene und ihre verwendungen
ATE317441T1 (de) Cathepsin-02-protease
DE69738873D1 (de) Mutierte penicillin g acylasen
WO1994012637A3 (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
DE59912185D1 (de) Verwendung von hsp70 protein
NO974035L (no) En ny vekstfaktor og en genetisk sekvens som koder for denne
ATE308619T1 (de) Steigerung der genexpression
EP0737249A4 (en) THE TUMORE-REPRESSING PROTEIN PRB2, RELATED GENE PRODUCTS, AND THE ENCODING DNA
FR2744455B1 (fr) Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
WO1998008965A3 (en) Cd95 regulatory gene sequences and transcription factors
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
AU4333793A (en) Modified kluyveromyces yeasts, their preparation and use
NO951315D0 (no) Ökt produksjon av utsondrede proteiner fra rekombinante eukaryote-celler
AU2002350545A1 (en) Use of the adenoviral e2 late promoter
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi
ATE93893T1 (de) Expressionssysteme zur ueberproduktion gewuenschter proteine.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
MK1K Patent expired